Abstract
Over the past decades, allogeneic bone marrow transplantation (BMT), also called allogeneic haematopoietic stem cell transplantation (HSCT), has been progressively refined. It evolved from last-resort experiments to first-line therapy for various haematolymphoid malignancies and a few other metabolic disorders. Despite effective immunosuppressive regimens, allogeneic graft-versus-host disease (GVHD) remains a serious and common complication of BMT; mortality increases with GVHD severity [1]. GVHD has also been documented following transplantation of solid organs containing passenger leukocytes. This latter situation is notable for its rarity and its association with high mortality [2]. Contrasting with its deleterious effects, GVHD exhibits an antitumoral effect termed the graf-tversus-leukaemia effect. Such a beneficial aspect has also been reported in multiple myeloma and breast cancer.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aractingi S, Chosidow O (1998) Cutaneous graft-versus-host disease. Arch Dermatol 134:602–612
Schmuth M, Vogel W, Weinlich G, Margreiter R, Fritsch P, Sepp N (1999) Cutaneous lesions as the presenting sign of acute graft-versus-host disease following liver transplantation. Br J Dermatol 141:901–904
Lerner KG, Kao GF, Storb R, Buckner CD, Clift RA, Thomas ED (1974) Histopathology of graft-vs.-host reaction (GvHR) in human recipients of marrow from HLA-matched sibling donors. Transplant Proc 6:367–371
Villada G, Roujeau JC, Cordonnier C, Bagot M, Kuentz M, Wechsler J, Vernant JP (1990) Toxic epidermal necrolysis after bone marrow transplantation: study of nine cases. J Am Acad Dermatol 23:870–875
McDonald BJ, Singer JW, Bianco JA (1992) Toxic epidermal necrolysis possibly linked to aztreonam in bone marrow transplant patients. Ann Pharmacother 26:34–35
Stone N, Sheerin S, Burge S (1999) Toxic epidermal necrolysis and graft vs. host disease: a clinical spectrum but a diagnostic dilemma. Clin Exp Dermatol 24:260–262
Wilke M, Poole J, den Hann JM, Goulmy E (1998) Genomic identification of the minor histocompatibility antigen HA-1 locus by allele-specific PCR. Tissue Antigens 52: 303–304
Paller AS, Nelson A, Steffan L, Gottschalk L, Kaizer (1988) T-lymphocyte subsets in the lesional skin of allogeneic and autologous bone marrow transplant patients. Arch Dermatol 124:1795–1801
Favre A, Amilcare C, Bacigalupo A, Lanino E, Berti E, Grossi C (1987) Immuno-histochemical study of skin lesions in acute and chronic graft-versus-host disease following bone marrow transplantation. Am J Surg Pathol 21:23–24
DeBueger M, Bakker A, Van Rood JJ, Goulmy E (1991) Minor histocompatibility antigens, defined by graft-vs.-host disease-derived cytotoxic T lymphocytes show variable expression on human skin cells. Eur J Immunol 21:2839–2344
Horn TD, Haskell J (1998) The lymphocytic infiltrate in acute cutaneous allogeneic graft-versus-host reactions lacks evidence for phenotypic restriction in donor-derived cells. J Cutan Pathol 25:210–214
Dietrich PY, Caignard A, Lim A, et al. (1994) In vivo T-cell clonal amplification at time of graft-versus-host disease. Blood 84:2815–2820
Liu X, Chesnokova V, Forman SJ, Diamond DJ (1996) Molecular analysis of T-cell receptor repertoire in bone marrow transplant recipients: evidence for oligoclonal T-cell expansion in graft-versus-host disease. Blood 87:3032–3044
Facon T, Janin A, Noel MP, Jouet JP (1995) Involvement of macrophages in lethal forms of graft-versus-host disease. Lancet 345:392
Facon T, Jouet JP, Noel-Walter MP, Bloget F, Bauters F, Janin A (1987) Involvement of TNF-a secreting macrophages in lethal forms of human graft-versus-host disease. Bone Marrow Transplant 20:511–515
Yoo YH, Park BS, Whitaker-Menezes D, Korngold R, Murphy G (1998) Dermal dendrocytes participate in the cellular pathology of experimental acute graft-versus-host-disease. J Cut Pathol 25:426–434
Piérard GE, Nikkels-Tassoudji N, Arrese J, Nikkels A, Hermanns-Lê T, Piérard-Franchimont C (1998) Ll-protein in incipient lymphocyte-depleted graft-versus-host disease. Expression in keratinocytes and co-expression with factor XIIIa in dermal cells. Turk J Dermatopathol 7:10–13
Ferrara J, Deeg HJ (1999) Graft-versus-host-disease. N Engl J Med 324:667–374
Hermanns-Lê T, Paquet P, Piérard-Franchimont C, Arrese J, Piérard GE (1999) Regulatory function of Factor XIIIa-positive dendrocytes in incipient toxic epidermal necrolysis and graft-versus-host reaction. Dermatology 198:184–186
Krenger W, Hill GR, Ferrara J (1987) Cytokine cascades in acute graft-versus-host disease. Transplantation 64:553–558
Nestel F, Price K, Seemayer T, Lapp W (1992) Macrophage priming and lipopolysaccharide triggered release of TNF-alpha during graft versus host disease. J Exp Med 175:405–413
Barbaud A, Bené MC, Faure G (1987) Immunological physiopathology of cutaneous adverse reactions. Eur J Dermatol 7:319–323
Paquet P, Piérard GE (1999) Would cyclosporin A be beneficial to mitigate drug-induced toxic epidermal necrolysis? Dermatology 198:198–202
Takata M (1995) Immunohistochemical identification of perforin-positive cytotoxic lymphocytes in graft-versus-host disease. Am J Clin Pathol 103:324–329
Gilliam A, Whitaker-Menezes D, Korngold R, Murphy G (1996) Apoptosis is the predominant form of epithelial target cell injury in acute experimental graft versus host disease. J Invest Dermatol 107:377–383
Paul C, Wolkenstein P, Adle H, Wechsler J, Garchon HJ, Revuz J, Roujeau JC (1996) Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis. Br J Dermatol 134:710–714
Via C, Nguyen P, Shoustov A, Drappa J, Elkon KB (1996) A major role for the Fas pathway in acute graft-versus-host disease. J Immunol 157:5387–5393
Yoo YH, Gillian AC, Whitaker-Menezes D, Korngold R, Murphy G (1987) Experimental induction and ultrastructural characterization of apoptosis in murine acute cutaneous graft-versus-host disease. Arch Dermatol Res 289:389–398
Viard I, Wehrili P, Bullani R, Schneider P, Holler N, Salomon D, Hunzcker T, Saurat JH, Tschopp J, French LE (1998) Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Sciences 282:490–493
Kohler S, Hendrickson MR, Chao NJ, Smoller BR (1987) Value of skin biopsies in assessing prognosis and progression of acute graft-versus-host disease. Am J Surg Pathol 11:988–996
Elliot CJ, Sloane JP, Sanderson KV, Vincent M, Shepherd V, Powles R (1987) The histological diagnosis of cutaneous graft versus host disease: relationship of skin changes to marrow purging and other clinical variables. Histopathology 11:145–155
Johnson ML, Farmer ER (1998) Graft-versus-host reactions in dermatology. J Am Acad Dermatol 38:369–392
Horn TD, Zahurak ML, Atkins E, et al. (1997) Lichen planus-like histopathologic characteristics in the cutaneous graft-vs-host reaction. Prognostic significance independent of time course after allogeneic bone marrow transplantation. Arch Dermatol 133:961–965
Horn TD (1994) Acute cutaneous eruptions after marrow ablation: roses by other names? J Cutan Pathol 21:385–392
Hymes SR, Farmer ER, Lewis PG, Tutschka PJ, Santos GW (1985) Cutaneous graft-versushost reaction: prognostic features seen by light microscopy. J Am Acad Dermatol 12: 468–474
Sviland L, Pearson AD, Eastham EJ, Hamilton PJ, Proctor SJ, Malcom AJ (1988) Histological features of skin and rectal biopsy specimens after autologous and allogeneic bone marrow transplantation. J Clin Pathol 41:148–154
Snover D (1990) The pathology of acute graft-vs-host disease. In: Burakoff SJ (ed) Graft-vshost disease: immunology, pathophysiology, and treatment. M. Dekker, New York, pp 337–353
Piérard GE, Nikkels-Tassoudji N, Nikkels A, Arrese J, Piérard-Franchimont C, Jerusalem G, Beguin Y, Fillet G (1998) Epidermal calprotectin expression in lymphocyte-depleted cutaneous graft-versus-host reaction. Arch Argent Dermatol 48:139–142
Saurat JH (1981) Cutaneous manifestations of graft-versus-host disease. Int J Dermatol 20:249–256
Paquet P et Piérard GE (1987) Erythema multiforme and toxic epidermal necrolysis.A comparative study. Am J Dermatopathol 19:127–132
Akosq AB, Elhag AM (1995) Toxic epidermal necrolysis. A study of the sweat glands. J Cutan Pathol 22:359–364
Drijkoningen M, De Wolf-Peeters C, Tricot G, Degreef H, Desmet V (1988) Drug-induced skin reactions and acute cutaneous graft-versus-host reaction: a comparative immunohisto chemical study. Blood 56:69–73
Sloane J, Thomas J, Imrie S, Easton D, Powlers R (1984) Morphological and immunohistological changes in the skin in allogeneic bone marrow recipients. J Clin Pathol 37:919–930
Dreno B, Milpied N, Harousseau J, et al. (1986) Cutaneous immunological studies in the diagnosis of acute graft-versus-host disease. Br J Dermatol 114:7–15
Lever R, Turbitt M, Mackie R (1986) A prospective study of the histological changes in the skin in patients receiving bone marrow transplants. Br J Dermatol 114:161–170
Elliott C, Sloane J, Pallett C, Sanderson K (1988) Cutaneous leucocyte composition after human allogeneic bone marrow transplantation: relationship to marrow purging, histology and clinical rash. Histopathology 12:1–16
Paller S, Nelson A, Steffen L, Gottschalk L, Kaiser H (1988) T-lymphocyte subsets in the lesional skin of allogeneic and autologous bone marrow transplant patients. Arch Dermatol 124:1795–1801
Volc-Platzer B, Rappersberger K, Mosberger I, et al. (1988) Sequential immunohistologic analysis of the skin following allogeneic bone marrow transplantation. J Invest Dermatol 91:162–168
Girolomoni G, Pincelli C, Zambruno G, et al. (1991) Immunohistochemistry of cutaneous graft-versus-host disease after allogeneic bone marrow transplantation. J Dermatol 18: 314–323
Sviland L, Pearson A, Green M, et al. (1991) Immunopathology of early graft-versus-host disease: a prospective study of skin, rectum, and peripheral blood in allogeneic and autologous bone marrow transplant recipients. Transplantation 52:1029–1036
Leskinen R, Taskinen E, Volin L, Ruutu T, Häyry P (1992) Immunohistology of skin and rectum biopsies in bone marrow transplant recipients. APMIS 100:1115–1122
Takeda H, Mitsuhashi Y, Kondo S, Koto Y, Tajima K (1987) Toxic epidermal necrolysis possibly linked to hyperacute graft-versus-host disease after allogeneic bone marrow transplantation. J Dermatol 24:635–641
Horn TD, Haskell J (1998) The lymphocytic infiltrate in acute cutaneous allogeneic graft-versus-host reactions lacks evidence for phenotypic restriction in donor-derived cells. J Cutan Pathol 25:210–214
Lampert IA, Janossy G, Suitters A, Bofill M, Palmer S, Gordon-Smith E, Prentice HG, Alero Thomas J (1982) Immunological analysis of the skin in graft versus host disease. Clin Exp Immunol 50:123–131
Acevedo A, Aramburu J, Lopez J, Fernandez-Herrera J, Fernandez-Ranada J, Lopez-Botet M (1991) Identification of natural killer (NK) cells in lesions of human cutaneous graft-versus-host disease: expression of a novel NK-associated surface antigen (Kp43) in mononuclear infiltrates. J Invest Dermatol 97:659–666
Merot Y, Gravallese E, Grullen F, Murphy G (1986) Lymphocyte subsets and Langerhans cells in toxic epidermal necrolysis. Arch Dermatol 122:455–458
Heng MCY, Allen S (1991) Efficacy of cyclophosphamide in toxic epidermal necrolysis. J Am Acad Dermatol 25:7789786
Miyauchi H, Hosokawa H, Akaeda T, Iba H, Asada Y (1991) T-cell subsets in drug-induced toxic epidermal necrolysis. Arch Dermatol 127:851–855
Villada G, Roujeau JC, Clerici T, Bourgault I, Revuz J (1992) Immunopathology of toxic epidermal necrolysis. Arch Dermatol 128:50–53
Correia O, Delgado L, Ramos J, Resende C, Fleming Torrinha JA (1993) Cutaneous T-cell recruitment in toxic epidermal necrolysis. Arch Dermatol 129:466–468
Friedmann P, Strickland E, Permohamed M, Park K (1994) Investigation of mechanisms in toxic epidermal necrolysis induced by carbamazepine. Arch Dermatol 130:598–604
Paquet P, Nikkels A, Arrese J, Vanderkelen A, Piérard GE (1994) Macrophages and tumor necrosis factor-a in toxic epidermal necrolysis. Arch Dermatol 130:605–608
Friedman HZ, Acias AM, Catchatourian R, Fretzen D (1984) Toxic epidermal necrolysis following bone marrow transplantation. Cutis 34:158–162
Roujeau JC, Dubertret L, Moritz D (1985) Involvement of macrophages in toxic epidermal necrolysis. Br J Dermatol 113:425–430
Paquet P, Piérard GE (1999) Epidermal calprotectin in drug-induced toxic epidermal necrolysis. J Cutan Pathol 26:301–305
Pimpinelli N, Romagnoli A, Alberto B, Santucci M, Mori M, Guidi S Gianotti B (1993) Dendritic cells in the skin after allogeneic bone marrow transplantation: immunohistochemical and electron microscopy monitoring. Eur J Dermatol 3:310–317
Murphy GF, Merot Y, Tang ALF (1985) Depletion and repopulation of epidermal dendritic cells after allogeneic bone marrow transplantation in humans. J Invest Dermatol 84: 210–214
Perreault C, Pelletier M, Landry D, Gyger M (1995) Study of Langerhans’ cells after allogeneic bone marrow transplantation. Blood 63:807–811
Norton J, Sloane JP (1991) ICAM-1 expression on epidermal keratinocytes in cutaneous graft-versus-host disease. Transplantation 53:1518–1523
Dumler J, Beschorner W, Farmer E, DiGennaro K, Saral R, Santos G (1989) Endothelial cell injury in cutaneous acute graft-versus-host disease. Am J Pathol 135:1097–1103
Shen N, French P, Guyotat D (1994) Expression of adhesion molecules in endothelial cells during allogeneic bone marrow transplantation. Eur J Haematol 52:29
Jack MK, Jack GM, Sale GE, Schulman HM, Sullivan KM (1983) Ocular manifestations of graft-versus-host disease. Arch Ophthalmol 101:1080–1084
Peck GL, Herzig GP, Elios PM (1972) Toxic epidermal necrolysis in a patient with graft-versus-host reaction. Arch Dermatol 105:561–569
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Paquet, P., Arrese, J.E., Beguin, Y., Piérard, G.E. (2001). Clinicopathological Differential Diagnosis of Drug-Induced Toxic Epidermal Necrolysis (Lyell’s Syndrome) and Acute Graft-Versus-Host Reaction. In: Cerio, R. (eds) Dermatopathology. Current Topics in Pathology, vol 94. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59552-3_3
Download citation
DOI: https://doi.org/10.1007/978-3-642-59552-3_3
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-64024-7
Online ISBN: 978-3-642-59552-3
eBook Packages: Springer Book Archive